Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myomas and pregnancy

J P Phelan1

  • 1Department of Maternal Fetal Medicine, Pomona Valley Hospital Medical Center, California, USA.

Obstetrics and Gynecology Clinics of North America
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Predicting uterine myoma growth during pregnancy is currently not possible. Complications often depend on the placenta-myoma contact, with lower segment myomas increasing cesarean birth risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models.

BMC cancer·2016
Same author

Predicting carotid artery disease and plaque instability from cell-derived microparticles.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014
Same author

The Effects of Evolution are Local: Evidence from Experimental Evolution in Drosophila.

Integrative and comparative biology·2011
Same author

Backbone 1H, 13C, and 15N resonance assignments for a 14 kD protein, GABA(A) receptor associated protein (GABARAP).

Journal of biomolecular NMR·2001
Same author

Fetal heart rate observations in the brain-damaged infant.

Seminars in perinatology·2000
Same author

Nucleated red blood cells in term infants.

American journal of obstetrics and gynecology·2000
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Reproductive Medicine

Background:

  • Uterine myomas (fibroids) are common in women of reproductive age.
  • Myoma growth and complications during pregnancy are not well understood.
  • Myoma location and number can impact pregnancy outcomes.

Purpose of the Study:

  • To review the impact of uterine myomas on pregnancy.
  • To outline management strategies for pregnant women with myomas.

Main Methods:

  • Literature review on uterine myomas in pregnancy.
  • Analysis of factors influencing pregnancy complications.
  • Discussion of diagnostic and therapeutic approaches.

Main Results:

  • Uterine myoma growth during pregnancy is unpredictable.

Related Experiment Videos

  • Placental-myoma contact is linked to major pregnancy complications.
  • Myomas in the lower uterine segment increase risks of cesarean birth and fetal malpresentation.
  • Conclusions:

    • Frequent ultrasound monitoring of fetal growth, presentation, and myoma size is recommended.
    • Surgical resection is typically reserved for symptomatic pedunculated myomas.
    • Myoma resection should be considered before the next pregnancy for women with complications.